J Ramos

No ORCID on file · 4 papers in corpus
article 1997
Clinical, endocrine, and metabolic effects of two doses of gestrinone in treatment of pelvic endometriosis
American journal of obstetrics and gynecology ·doi:10.1016/s0002-9378(97)70504-0

ObjectiveOur purpose was to determine and compare the efficacy and hormonal and metabolic effects of 1.25 mg with 2.5 mg of gestrinone given twice a week in the treatment of mild and moderate pelvic endometriosis.Study designA phase II, pro…

rct 1995
Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin
Fertility and sterility ·doi:10.1016/s0015-0282(16)57593-1

OBJECTIVE: To determine changes in trabecular vertebral bone mass, serum E2, and serum calcitonin during and after therapy of pelvic endometriosis with depot leuprolide acetate (LA) or danazol. DESIGN: Prospective, randomized, double-blind…

other 1989
Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol
Fertility and sterility ·doi:10.1016/s0015-0282(16)60782-3

Cortical bone (distal radius and ulna) and trabecular bone mineral content of the thoracolumbar vertebrae (T-12 to L-4) were measured with single-photon absorptiometry and quantitative computed tomography, respectively, in 55 women with lap…

article 1988
Plasma and peritoneal fluid levels of CA 125 in women with endometriosis
American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(88)90588-1

Determined by a sandwich, solid-phase radioimmunoassay with mouse monoclonal antibody, OC 125, plasma CA 125 levels were significantly elevated in stage III (mean +/- SEM = 32.7 +/- 5.2 U/ml, n = 17, p = less than 0.01) and stage IV endomet…